SIMILAR PATTERNS OF AMINO ACIDS FOR 3OCT_A_1N1A663_2

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1c39 CATION-DEPENDENT
MANNOSE-6-PHOSPHATE
RECEPTOR


(Bos taurus)
PF02157
(Man-6-P_recep)
4 ILE A  95
MET A 147
ASN A 127
PHE A  86
None
1.28A 3octA-1c39A:
undetectable
3octA-1c39A:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1d7b CELLOBIOSE
DEHYDROGENASE


(Phanerochaete
chrysosporium)
PF16010
(CDH-cyt)
4 PHE A 166
ILE A  57
MET A  65
PHE A 145
HEM  A 401 (-3.8A)
None
HEM  A 401 (-2.3A)
None
1.29A 3octA-1d7bA:
0.0
3octA-1d7bA:
19.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ea9 CYCLOMALTODEXTRINASE

(Bacillus sp.
(in: Bacteria))
PF00128
(Alpha-amylase)
PF02903
(Alpha-amylase_N)
PF16657
(Malt_amylase_C)
4 PHE C 133
MET C 372
ASN C 373
PHE C 191
None
1.27A 3octA-1ea9C:
0.0
3octA-1ea9C:
17.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fft UBIQUINOL OXIDASE

(Escherichia
coli)
PF00115
(COX1)
PF00510
(COX3)
4 PHE A 208
ILE C  31
ASN A 143
PHE A 209
None
1.31A 3octA-1fftA:
1.6
3octA-1fftA:
16.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jjo NEUROSERPIN

(Mus musculus)
PF00079
(Serpin)
4 PHE E 384
ILE C 297
ASN C 166
PHE A  52
None
1.24A 3octA-1jjoE:
undetectable
3octA-1jjoE:
9.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1klq MITOTIC SPINDLE
ASSEMBLY CHECKPOINT
PROTEIN MAD2A


(Homo sapiens)
PF02301
(HORMA)
4 PHE A  26
ILE A  21
ASN A  69
PHE A  25
None
0.99A 3octA-1klqA:
0.0
3octA-1klqA:
24.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1mo0 TRIOSEPHOSPHATE
ISOMERASE


(Caenorhabditis
elegans)
PF00121
(TIM)
4 PHE A   6
ILE A 225
ASN A 158
PHE A 228
None
1.08A 3octA-1mo0A:
0.0
3octA-1mo0A:
23.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1npu PROGRAMMED CELL
DEATH PROTEIN 1


(Mus musculus)
PF07686
(V-set)
4 PHE A  49
ILE A  93
MET A  75
ASN A  76
None
1.30A 3octA-1npuA:
0.0
3octA-1npuA:
18.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ofe FERREDOXIN-DEPENDENT
GLUTAMATE SYNTHASE 2


(Synechocystis
sp. PCC 6803)
PF00310
(GATase_2)
PF01493
(GXGXG)
PF01645
(Glu_synthase)
PF04898
(Glu_syn_central)
4 PHE A  78
ILE A 155
MET A 221
PHE A 163
None
1.31A 3octA-1ofeA:
undetectable
3octA-1ofeA:
11.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q47 SEMAPHORIN 3A

(Mus musculus)
PF01403
(Sema)
4 ILE A 201
MET A 409
ASN A 411
PHE A 245
None
1.38A 3octA-1q47A:
undetectable
3octA-1q47A:
19.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zwx SPHINGOMYELINASE-C

(Listeria
ivanovii)
PF03372
(Exo_endo_phos)
4 PHE A 285
ILE A  47
ASN A 233
PHE A 225
None
1.35A 3octA-1zwxA:
undetectable
3octA-1zwxA:
21.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zy9 ALPHA-GALACTOSIDASE

(Thermotoga
maritima)
PF02065
(Melibiase)
4 PHE A 364
ILE A 256
ASN A 455
PHE A 324
None
1.18A 3octA-1zy9A:
undetectable
3octA-1zy9A:
19.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2b4v RNA EDITING COMPLEX
PROTEIN MP57


(Trypanosoma
brucei)
PF01909
(NTP_transf_2)
PF03828
(PAP_assoc)
4 ILE A  61
MET A 263
ASN A 154
PHE A  57
None
1.12A 3octA-2b4vA:
undetectable
3octA-2b4vA:
20.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bfe 2-OXOISOVALERATE
DEHYDROGENASE ALPHA
SUBUNIT


(Homo sapiens)
PF00676
(E1_dh)
4 PHE A 218
MET A 284
ASN A 256
PHE A 217
None
1.32A 3octA-2bfeA:
undetectable
3octA-2bfeA:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cb4 MOSQUITOCIDAL TOXIN

(Lysinibacillus
sphaericus)
no annotation 4 PHE A 107
ILE A 230
ASN A 252
PHE A 229
None
1.40A 3octA-2cb4A:
undetectable
3octA-2cb4A:
20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dvm 439AA LONG
HYPOTHETICAL MALATE
OXIDOREDUCTASE


(Pyrococcus
horikoshii)
PF00390
(malic)
PF03949
(Malic_M)
4 PHE A 270
ILE A 278
ASN A 327
PHE A 192
NAD  A2503 ( 4.7A)
None
None
None
1.17A 3octA-2dvmA:
undetectable
3octA-2dvmA:
20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2e1b 216AA LONG
HYPOTHETICAL
ALANYL-TRNA
SYNTHETASE


(Pyrococcus
horikoshii)
PF01411
(tRNA-synt_2c)
PF07973
(tRNA_SAD)
4 ILE A  36
MET A   4
ASN A   3
PHE A  37
None
1.25A 3octA-2e1bA:
undetectable
3octA-2e1bA:
20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fwu SODIUM/CALCIUM
EXCHANGER 1


(Canis lupus)
PF03160
(Calx-beta)
4 PHE A 505
ILE A 571
ASN A 564
PHE A 507
None
1.39A 3octA-2fwuA:
undetectable
3octA-2fwuA:
23.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gbx BIPHENYL
2,3-DIOXYGENASE
ALPHA SUBUNIT


(Sphingobium
yanoikuyae)
PF00355
(Rieske)
PF00848
(Ring_hydroxyl_A)
4 PHE A 201
ILE A 313
ASN A 363
PHE A 311
BNL  A 457 ( 4.2A)
None
None
None
1.36A 3octA-2gbxA:
undetectable
3octA-2gbxA:
19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gep SULFITE REDUCTASE
HEMOPROTEIN


(Escherichia
coli)
PF01077
(NIR_SIR)
PF03460
(NIR_SIR_ferr)
4 PHE A 274
ILE A 329
MET A 235
ASN A 233
None
1.35A 3octA-2gepA:
undetectable
3octA-2gepA:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gzq PHOSPHATIDYLETHANOLA
MINE-BINDING PROTEIN


(Plasmodium
vivax)
PF01161
(PBP)
4 PHE A  74
ILE A  59
ASN A 143
PHE A 134
None
1.10A 3octA-2gzqA:
undetectable
3octA-2gzqA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hae MALATE
OXIDOREDUCTASE


(Thermotoga
maritima)
PF00390
(malic)
PF03949
(Malic_M)
4 PHE A 255
ILE A 300
ASN A 262
PHE A 254
None
1.34A 3octA-2haeA:
undetectable
3octA-2haeA:
21.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2i54 PHOSPHOMANNOMUTASE

(Leishmania
mexicana)
PF03332
(PMM)
4 PHE A  67
ILE A  59
ASN A  84
PHE A  63
None
1.38A 3octA-2i54A:
undetectable
3octA-2i54A:
23.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ilu ALDEHYDE
DEHYDROGENASE A


(Escherichia
coli)
PF00171
(Aldedh)
4 PHE A 107
ILE A  90
ASN A 441
PHE A 156
None
1.23A 3octA-2iluA:
undetectable
3octA-2iluA:
19.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jaq DEOXYGUANOSINE
KINASE


(Mycoplasma
mycoides)
PF01712
(dNK)
4 ILE A  74
MET A 195
ASN A 196
PHE A  76
None
1.36A 3octA-2jaqA:
undetectable
3octA-2jaqA:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2k7b CALCIUM-BINDING
PROTEIN 1


(Homo sapiens)
PF13499
(EF-hand_7)
4 PHE A  31
ILE A  24
MET A  51
ASN A  49
None
1.16A 3octA-2k7bA:
undetectable
3octA-2k7bA:
13.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2kna BACULOVIRAL IAP
REPEAT-CONTAINING
PROTEIN 4


(Homo sapiens)
no annotation 4 PHE A  39
ILE A  25
ASN A  71
PHE A  41
None
1.24A 3octA-2knaA:
undetectable
3octA-2knaA:
18.70
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2og8 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE LCK


(Homo sapiens)
PF07714
(Pkinase_Tyr)
4 PHE A 383
ILE A 314
MET A 319
ASN A 321
1N8  A 501 ( 4.3A)
1N8  A 501 ( 4.6A)
1N8  A 501 ( 4.4A)
None
0.87A 3octA-2og8A:
31.0
3octA-2og8A:
42.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2oz6 VIRULENCE FACTOR
REGULATOR


(Pseudomonas
aeruginosa)
PF00027
(cNMP_binding)
PF00325
(Crp)
4 PHE A  71
ILE A  32
MET A 125
PHE A  42
None
CMP  A 301 ( 4.3A)
None
None
1.36A 3octA-2oz6A:
undetectable
3octA-2oz6A:
19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pnc COPPER AMINE
OXIDASE, LIVER
ISOZYME


(Bos taurus)
PF01179
(Cu_amine_oxid)
PF02727
(Cu_amine_oxidN2)
PF02728
(Cu_amine_oxidN3)
4 ILE A 290
MET A 210
ASN A 211
PHE A 498
None
1.22A 3octA-2pncA:
undetectable
3octA-2pncA:
15.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qfe CALPAIN-7

(Homo sapiens)
PF01067
(Calpain_III)
4 PHE A 801
ILE A 781
ASN A 693
PHE A 782
None
None
BR  A   5 ( 4.8A)
None
1.35A 3octA-2qfeA:
undetectable
3octA-2qfeA:
21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2reu TYPE II RESTRICTION
ENZYME SAU3AI


(Staphylococcus
aureus)
no annotation 4 PHE A 143
ILE A 140
ASN A 246
PHE A 142
None
1.41A 3octA-2reuA:
undetectable
3octA-2reuA:
21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wch GENERAL
ODORANT-BINDING
PROTEIN 1


(Bombyx mori)
PF01395
(PBP_GOBP)
4 PHE A  80
ILE A 127
MET A  73
ASN A  72
None
None
B7M  A1145 (-4.4A)
None
1.39A 3octA-2wchA:
undetectable
3octA-2wchA:
20.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xy3 SPBC2
PROPHAGE-DERIVED
DEOXYURIDINE
5'-TRIPHOSPHATE
NUCLEOTIDOHYDROLASE
YOSS


(Bacillus
subtilis)
PF00692
(dUTPase)
4 PHE A  91
ILE A 108
ASN A  87
PHE A  92
DUP  A1130 (-3.3A)
None
None
None
1.35A 3octA-2xy3A:
undetectable
3octA-2xy3A:
19.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2z0b PUTATIVE
GLYCEROPHOSPHODIESTE
R PHOSPHODIESTERASE
5


(Homo sapiens)
PF00686
(CBM_20)
4 PHE A  74
ILE A  15
ASN A  36
PHE A  25
None
0.99A 3octA-2z0bA:
undetectable
3octA-2z0bA:
18.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2za1 OROTIDINE
5'-PHOSPHATE
DECARBOXYLASE


(Plasmodium
falciparum)
PF00215
(OMPdecase)
4 PHE A  79
ILE A  62
MET A  33
ASN A  31
None
1.37A 3octA-2za1A:
undetectable
3octA-2za1A:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3doa FIBRINOGEN BINDING
PROTEIN


(Staphylococcus
aureus)
PF05833
(FbpA)
4 PHE A 251
ILE A 205
ASN A  54
PHE A 253
None
1.38A 3octA-3doaA:
undetectable
3octA-3doaA:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dsl ZINC
METALLOPROTEINASE-DI
SINTEGRIN
BOTHROPASIN


(Bothrops
jararaca)
PF00200
(Disintegrin)
PF01421
(Reprolysin)
PF08516
(ADAM_CR)
4 PHE A 181
ILE A 187
MET A  52
ASN A  44
None
1.28A 3octA-3dslA:
undetectable
3octA-3dslA:
20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ei8 LL-DIAMINOPIMELATE
AMINOTRANSFERASE


(Arabidopsis
thaliana)
PF00155
(Aminotran_1_2)
4 PHE A 204
ILE A 132
ASN A 361
PHE A 203
None
1.21A 3octA-3ei8A:
undetectable
3octA-3ei8A:
19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eqn GLUCAN
1,3-BETA-GLUCOSIDASE


(Phanerochaete
chrysosporium)
PF12708
(Pectate_lyase_3)
4 PHE A 653
ILE A 613
ASN A 621
PHE A 647
None
1.37A 3octA-3eqnA:
undetectable
3octA-3eqnA:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fgb UNCHARACTERIZED
PROTEIN Q89ZH8_BACTN


(Bacteroides
thetaiotaomicron)
PF10282
(Lactonase)
4 PHE A 102
ILE A 149
ASN A  73
PHE A  85
None
1.13A 3octA-3fgbA:
undetectable
3octA-3fgbA:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gei TRNA MODIFICATION
GTPASE MNME


(Chlorobaculum
tepidum)
PF01926
(MMR_HSR1)
PF10396
(TrmE_N)
PF12631
(MnmE_helical)
4 PHE A 466
ILE A  15
ASN A 458
PHE A 125
None
1.27A 3octA-3geiA:
undetectable
3octA-3geiA:
19.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ll3 GLUCONATE KINASE

(Lactobacillus
acidophilus)
PF00370
(FGGY_N)
PF02782
(FGGY_C)
4 PHE A 334
ILE A 414
ASN A 302
PHE A 376
None
None
ATP  A1760 (-4.6A)
None
1.26A 3octA-3ll3A:
undetectable
3octA-3ll3A:
18.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n9o PUTATIVE
UNCHARACTERIZED
PROTEIN


(Caenorhabditis
elegans)
PF02373
(JmjC)
4 PHE A 494
ILE A 561
ASN A 545
PHE A 514
None
1.26A 3octA-3n9oA:
undetectable
3octA-3n9oA:
19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ncy ADIC

(Salmonella
enterica)
PF13520
(AA_permease_2)
4 PHE A  29
ILE A 246
ASN A 198
PHE A 262
None
1.35A 3octA-3ncyA:
undetectable
3octA-3ncyA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nr5 REPRESSOR OF RNA
POLYMERASE III
TRANSCRIPTION MAF1
HOMOLOG


(Homo sapiens)
PF09174
(Maf1)
4 PHE A 154
ILE A 151
ASN A 105
PHE A 142
None
1.33A 3octA-3nr5A:
undetectable
3octA-3nr5A:
19.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o5c CYTOCHROME C551
PEROXIDASE


(Shewanella
oneidensis)
PF00034
(Cytochrom_C)
PF03150
(CCP_MauG)
4 PHE A 227
MET A 279
ASN A 277
PHE A 247
None
HEM  A 501 (-2.3A)
None
None
1.41A 3octA-3o5cA:
undetectable
3octA-3o5cA:
23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oyo HEMOPEXIN FOLD
PROTEIN CP4


(Vigna
unguiculata)
PF00045
(Hemopexin)
4 PHE A  20
ILE A  64
ASN A 192
PHE A  10
None
1.15A 3octA-3oyoA:
undetectable
3octA-3oyoA:
20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ps5 TYROSINE-PROTEIN
PHOSPHATASE
NON-RECEPTOR TYPE 6


(Homo sapiens)
PF00017
(SH2)
PF00102
(Y_phosphatase)
4 PHE A 244
ILE A 488
ASN A 225
PHE A 248
None
1.35A 3octA-3ps5A:
undetectable
3octA-3ps5A:
18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r89 OROTIDINE
5'-PHOSPHATE
DECARBOXYLASE


(Anaerococcus
prevotii)
PF00215
(OMPdecase)
4 ILE A 140
MET A   1
ASN A  -1
PHE A 113
None
1.25A 3octA-3r89A:
undetectable
3octA-3r89A:
24.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3scy HYPOTHETICAL
BACTERIAL
6-PHOSPHOGLUCONOLACT
ONASE


(Bacteroides
fragilis)
PF10282
(Lactonase)
4 PHE A 103
ILE A 150
ASN A  74
PHE A  86
None
1.10A 3octA-3scyA:
undetectable
3octA-3scyA:
23.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3t5b PROBABLE
CHAIN-FATTY-ACID-COA
LIGASE FADD13


(Mycobacterium
tuberculosis)
PF00501
(AMP-binding)
4 PHE A 264
ILE A 254
ASN A 294
PHE A 257
None
1.27A 3octA-3t5bA:
undetectable
3octA-3t5bA:
18.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ti8 NEURAMINIDASE

(Influenza A
virus)
PF00064
(Neur)
4 ILE A 412
MET A 233
ASN A 236
PHE A 410
None
0.99A 3octA-3ti8A:
undetectable
3octA-3ti8A:
18.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tix CHROMO
DOMAIN-CONTAINING
PROTEIN 1


(Schizosaccharomyces
pombe)
no annotation 4 PHE B 767
ILE B 698
ASN B 939
PHE B 740
None
1.33A 3octA-3tixB:
undetectable
3octA-3tixB:
21.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u5u RAUCAFFRICINE-O-BETA
-D-GLUCOSIDASE


(Rauvolfia
serpentina)
PF00232
(Glyco_hydro_1)
4 ILE A  17
MET A 508
ASN A  87
PHE A  22
None
1.25A 3octA-3u5uA:
undetectable
3octA-3u5uA:
18.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3uem PROTEIN
DISULFIDE-ISOMERASE


(Homo sapiens)
PF00085
(Thioredoxin)
PF13848
(Thioredoxin_6)
4 PHE A 290
ILE A 301
ASN A 274
PHE A 240
None
D1D  A2815 ( 4.3A)
None
D1D  A2815 ( 4.4A)
1.35A 3octA-3uemA:
undetectable
3octA-3uemA:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3v0a NTNH

(Clostridium
botulinum)
PF01742
(Peptidase_M27)
PF07953
(Toxin_R_bind_N)
PF08470
(NTNH_C)
4 ILE B 684
MET B 817
ASN B 816
PHE B 681
None
1.35A 3octA-3v0aB:
undetectable
3octA-3v0aB:
12.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3v9f TWO-COMPONENT SYSTEM
SENSOR HISTIDINE
KINASE/RESPONSE
REGULATOR, HYBRID
(ONE-COMPONENT
SYSTEM)


(Bacteroides
thetaiotaomicron)
PF07494
(Reg_prop)
PF07495
(Y_Y_Y)
4 PHE A 668
ILE A 621
ASN A 403
PHE A 362
None
1.14A 3octA-3v9fA:
undetectable
3octA-3v9fA:
16.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wzf ASPARTATE
AMINOTRANSFERASE,
CYTOPLASMIC


(Homo sapiens)
PF00155
(Aminotran_1_2)
4 PHE A 220
ILE A 240
ASN A 142
PHE A 250
None
1.39A 3octA-3wzfA:
undetectable
3octA-3wzfA:
19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3x1l CRISPR SYSTEM CMR
SUBUNIT CMR2
CRISPR SYSTEM CMR
SUBUNIT CMR5


(Archaeoglobus
fulgidus;
Pyrococcus
furiosus)
PF09701
(Cas_Cmr5)
PF12469
(DUF3692)
4 PHE F  15
ILE F 139
MET A 810
PHE F  13
None
1.41A 3octA-3x1lF:
undetectable
3octA-3x1lF:
20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4aca TRANSLATION
ELONGATION FACTOR
SELB


(Methanococcus
maripaludis)
PF00009
(GTP_EFTU)
PF03144
(GTP_EFTU_D2)
4 PHE A 342
ILE A 387
MET A 297
PHE A 315
CMH  A 340 ( 4.2A)
None
None
CMH  A 340 ( 4.6A)
1.35A 3octA-4acaA:
undetectable
3octA-4acaA:
18.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4asc KELCH REPEAT AND BTB
DOMAIN-CONTAINING
PROTEIN 5


(Homo sapiens)
PF01344
(Kelch_1)
4 PHE A 321
ILE A 583
ASN A 614
PHE A 608
None
1.39A 3octA-4ascA:
undetectable
3octA-4ascA:
22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4cgn GLYCYLPEPTIDE
N-TETRADECANOYLTRANS
FERASE


(Leishmania
major)
PF01233
(NMT)
PF02799
(NMT_C)
4 PHE A  88
ILE A 328
ASN A 337
PHE A  90
None
None
None
7AH  A1000 (-3.9A)
1.24A 3octA-4cgnA:
undetectable
3octA-4cgnA:
20.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dkj CYTOSINE-SPECIFIC
METHYLTRANSFERASE


(Mycoplasma
penetrans)
PF00145
(DNA_methylase)
4 PHE A  24
ILE A 376
MET A  43
ASN A 109
None
1.35A 3octA-4dkjA:
undetectable
3octA-4dkjA:
22.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4euu SERINE/THREONINE-PRO
TEIN KINASE TBK1


(Homo sapiens)
PF00069
(Pkinase)
4 PHE A 158
ILE A  73
ASN A  66
PHE A  56
None
1.29A 3octA-4euuA:
21.5
3octA-4euuA:
24.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f5x RNA-DIRECTED RNA
POLYMERASE


(Rotavirus A)
PF02123
(RdRP_4)
PF12289
(Rotavirus_VP1)
4 PHE W 731
ILE W   7
ASN W 716
PHE W 147
None
1.29A 3octA-4f5xW:
undetectable
3octA-4f5xW:
13.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fdg MINICHROMOSOME
MAINTENANCE PROTEIN
MCM


(Sulfolobus
solfataricus)
no annotation 4 PHE B 478
MET B 593
ASN B 591
PHE B 474
None
1.36A 3octA-4fdgB:
undetectable
3octA-4fdgB:
15.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4g6v ADHESIN/HEMOLYSIN
CDII


(Burkholderia
pseudomallei)
no annotation 4 PHE B   6
ILE B  91
ASN A 231
PHE B  62
None
1.23A 3octA-4g6vB:
undetectable
3octA-4g6vB:
16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gct NUCLEOID OCCLUSION
FACTOR SLMA


(Vibrio cholerae)
PF00440
(TetR_N)
4 PHE A  50
ILE A  30
ASN A   8
PHE A  57
None
1.35A 3octA-4gctA:
undetectable
3octA-4gctA:
21.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hjw URACIL-5-CARBOXYLATE
DECARBOXYLASE


(Metarhizium
anisopliae)
PF04909
(Amidohydro_2)
4 PHE A 133
ILE A  91
MET A  15
PHE A 132
None
1.40A 3octA-4hjwA:
undetectable
3octA-4hjwA:
20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4koo SINGLE-STRANDED
DNA-BINDING PROTEIN
WHY1, CHLOROPLASTIC


(Arabidopsis
thaliana)
PF08536
(Whirly)
4 PHE A 140
ILE A 209
ASN A 198
PHE A 192
MES  A 302 (-4.2A)
None
None
None
1.39A 3octA-4kooA:
undetectable
3octA-4kooA:
20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4l7z HPCH/HPAI ALDOLASE

(Chloroflexus
aurantiacus)
PF03328
(HpcH_HpaI)
4 PHE A 264
ILE A 281
ASN A 291
PHE A 260
None
1.35A 3octA-4l7zA:
undetectable
3octA-4l7zA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mn8 LRR RECEPTOR-LIKE
SERINE/THREONINE-PRO
TEIN KINASE FLS2


(Arabidopsis
thaliana)
PF00560
(LRR_1)
PF08263
(LRRNT_2)
PF13516
(LRR_6)
PF13855
(LRR_8)
4 ILE A 700
MET A 650
ASN A 625
PHE A 694
None
1.23A 3octA-4mn8A:
undetectable
3octA-4mn8A:
16.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ohq TRIOSEPHOSPHATE
ISOMERASE,
CHLOROPLASTIC


(Arabidopsis
thaliana)
PF00121
(TIM)
4 PHE A   8
ILE A 227
ASN A 160
PHE A 230
None
1.19A 3octA-4ohqA:
undetectable
3octA-4ohqA:
19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4p0f SERINE PROTEASE
INHIBITOR 4, ISOFORM
B


(Drosophila
melanogaster)
PF00079
(Serpin)
4 PHE A 372
ILE A  33
ASN A 144
PHE A  35
None
1.09A 3octA-4p0fA:
undetectable
3octA-4p0fA:
20.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ph6 3-DEHYDROQUINATE
DEHYDRATASE


(Enterococcus
faecalis)
PF01487
(DHquinase_I)
4 PHE A  92
ILE A 115
ASN A  54
PHE A  98
None
1.25A 3octA-4ph6A:
undetectable
3octA-4ph6A:
19.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rt6 HEME/HEMOPEXIN-BINDI
NG PROTEIN


(Haemophilus
influenzae)
PF05860
(Haemagg_act)
4 PHE A 682
MET A 629
ASN A 630
PHE A 673
None
1.15A 3octA-4rt6A:
undetectable
3octA-4rt6A:
15.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rz2 SITE-DETERMINING
PROTEIN


(Geobacillus
thermodenitrificans)
PF10609
(ParA)
4 PHE A 188
ILE A 191
MET A 175
PHE A 159
None
1.09A 3octA-4rz2A:
undetectable
3octA-4rz2A:
21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wis LIPID SCRAMBLASE

([Nectria]
haematococca)
PF04547
(Anoctamin)
4 PHE A 388
ILE A 579
ASN A 317
PHE A 391
None
1.29A 3octA-4wisA:
undetectable
3octA-4wisA:
15.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xgc ORIGIN RECOGNITION
COMPLEX SUBUNIT 2


(Drosophila
melanogaster)
PF04084
(ORC2)
4 PHE B 485
ILE B 346
ASN B 436
PHE B 351
None
1.24A 3octA-4xgcB:
undetectable
3octA-4xgcB:
21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zro 3C-LIKE PROTEINASE

(Alphacoronavirus
1)
PF05409
(Peptidase_C30)
4 PHE A 158
ILE A 113
ASN A  96
PHE A 111
None
1.27A 3octA-4zroA:
undetectable
3octA-4zroA:
19.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cee NAD-DEPENDENT MALIC
ENZYME


(Aster yellows
witches'-broom
phytoplasma)
PF00390
(malic)
PF03949
(Malic_M)
4 PHE A 281
ILE A 290
ASN A 360
PHE A 257
None
0.95A 3octA-5ceeA:
undetectable
3octA-5ceeA:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ewx ENDOLYSIN,IMMUNOGLOB
ULIN G-BINDING
PROTEIN A,ENDOLYSIN


(Escherichia
virus T4;
Staphylococcus
aureus)
PF00959
(Phage_lysozyme)
PF02216
(B)
4 PHE A   4
ILE A 100
MET A   1
PHE A 104
None
1.21A 3octA-5ewxA:
1.8
3octA-5ewxA:
22.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h82 HETEROYOHIMBINE
SYNTHASE THAS2


(Catharanthus
roseus)
PF00107
(ADH_zinc_N)
PF08240
(ADH_N)
4 PHE A 213
ILE A 198
ASN A 331
PHE A 263
None
1.15A 3octA-5h82A:
undetectable
3octA-5h82A:
21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ijz NADP-SPECIFIC
GLUTAMATE
DEHYDROGENASE


(Corynebacterium
glutamicum)
PF00208
(ELFV_dehydrog)
PF02812
(ELFV_dehydrog_N)
4 PHE A 365
ILE A 224
ASN A 347
PHE A 341
None
None
AKG  A 502 ( 3.6A)
None
1.38A 3octA-5ijzA:
undetectable
3octA-5ijzA:
18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ip9 DNA-DIRECTED RNA
POLYMERASE II
SUBUNIT RPB1


(Saccharomyces
cerevisiae)
PF00623
(RNA_pol_Rpb1_2)
PF04983
(RNA_pol_Rpb1_3)
PF04990
(RNA_pol_Rpb1_7)
PF04992
(RNA_pol_Rpb1_6)
PF04997
(RNA_pol_Rpb1_1)
PF04998
(RNA_pol_Rpb1_5)
PF05000
(RNA_pol_Rpb1_4)
4 ILE A1227
MET A1267
ASN A1270
PHE A1225
None
1.37A 3octA-5ip9A:
2.3
3octA-5ip9A:
9.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5k94 MALTOSE-BINDING
PERIPLASMIC
PROTEIN,PROTEIN
TRANSLOCASE SUBUNIT
SECA,MALTOSE-BINDING
PERIPLASMIC PROTEIN


(Escherichia
coli)
PF01043
(SecA_PP_bind)
PF01547
(SBP_bac_1)
PF13416
(SBP_bac_8)
4 ILE A1178
MET A 305
ASN A 303
PHE A 169
None
1.37A 3octA-5k94A:
undetectable
3octA-5k94A:
19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mr3 VITELLINE ENVELOPE
SPERM LYSIN RECEPTOR


(Haliotis
rufescens)
PF11386
(VERL)
4 PHE B 181
ILE B 188
MET B 226
ASN B 225
GOL  B 901 (-4.4A)
None
None
None
0.94A 3octA-5mr3B:
undetectable
3octA-5mr3B:
19.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n7q PUTATIVE CATHEPSIN D

(Ixodes ricinus)
no annotation 4 PHE A 174
ILE A 177
MET A 145
ASN A 143
None
1.28A 3octA-5n7qA:
undetectable
3octA-5n7qA:
16.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n94 CG9323, ISOFORM A

(Drosophila
melanogaster)
no annotation 4 PHE A 845
ILE A 770
MET A 690
ASN A 689
None
1.33A 3octA-5n94A:
undetectable
3octA-5n94A:
17.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nvr TELOMERE LENGTH
REGULATOR PROTEIN
RIF1


(Saccharomyces
cerevisiae)
PF12231
(Rif1_N)
4 PHE A 778
ILE A 762
ASN A 681
PHE A 779
None
1.34A 3octA-5nvrA:
undetectable
3octA-5nvrA:
12.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5opq 3,6-ANHYDRO-D-GALACT
OSIDASE


(Zobellia
galactanivorans)
no annotation 4 PHE A 164
ILE A 272
ASN A  44
PHE A 274
None
1.41A 3octA-5opqA:
undetectable
3octA-5opqA:
16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t0l BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE


(Toxoplasma
gondii)
PF00186
(DHFR_1)
PF00303
(Thymidylat_synt)
4 ILE A 544
MET A 471
ASN A 457
PHE A 543
None
1.39A 3octA-5t0lA:
undetectable
3octA-5t0lA:
19.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5th3 R-SWAI PROTEIN

(Staphylococcus
warneri)
no annotation 4 PHE A 127
ILE A  18
ASN A 158
PHE A  94
None
0.93A 3octA-5th3A:
undetectable
3octA-5th3A:
21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5tz8 GLYCOSYL TRANSFERASE

(Staphylococcus
aureus)
PF00535
(Glycos_transf_2)
4 PHE A 517
ILE A 367
MET A 567
ASN A 563
None
1.37A 3octA-5tz8A:
undetectable
3octA-5tz8A:
18.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u4o ABC TRANSPORTER
SUBSTRATE-BINDING
PROTEIN


(Bacillus
anthracis)
PF00496
(SBP_bac_5)
4 ILE A 173
MET A  86
ASN A  85
PHE A 174
None
1.25A 3octA-5u4oA:
undetectable
3octA-5u4oA:
20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5v88 LYSOZYME,DCN1-LIKE
PROTEIN 1


(Escherichia
virus T4;
Homo sapiens)
PF00959
(Phage_lysozyme)
PF03556
(Cullin_binding)
4 PHE A   4
ILE A 100
MET A   1
PHE A 104
None
1.21A 3octA-5v88A:
1.7
3octA-5v88A:
19.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vbk LECTIN

(Mytilus
californianus)
no annotation 4 PHE A  42
ILE A  36
ASN A  23
PHE A  14
None
1.39A 3octA-5vbkA:
undetectable
3octA-5vbkA:
19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5yx9 SHORT TRANSIENT
RECEPTOR POTENTIAL
CHANNEL 6


(Homo sapiens)
no annotation 4 ILE A 682
MET A 652
ASN A 654
PHE A 679
None
1.36A 3octA-5yx9A:
2.0
3octA-5yx9A:
11.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bq1 PHOSPHATIDYLINOSITOL
4-KINASE III ALPHA
(PI4KA)


(Homo sapiens)
no annotation 4 PHE A1735
ILE A1741
ASN A1690
PHE A1737
None
1.40A 3octA-6bq1A:
3.8
3octA-6bq1A:
0.00